Select Medical Holdings Corp. (NYSE:SEM) issued an update on its FY16 earnings guidance on Tuesday morning. The company provided EPS guidance of $0.80-0.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.65. The company issued revenue guidance of $4.25-4.30 billion, compared to the consensus revenue estimate of $4.29 billion.

Shares of Select Medical Holdings Corp. (NYSE:SEM) opened at 12.70 on Tuesday. The firm has a 50-day moving average of $12.72 and a 200 day moving average of $12.15. The firm has a market capitalization of $1.68 billion, a price-to-earnings ratio of 13.51 and a beta of 1.07. Select Medical Holdings Corp. has a 52 week low of $7.33 and a 52 week high of $14.30.

Select Medical Holdings Corp. (NYSE:SEM) last posted its quarterly earnings data on Thursday, November 3rd. The company reported $0.06 EPS for the quarter, missing the Zacks’ consensus estimate of $0.15 by $0.09. Select Medical Holdings Corp. had a net margin of 2.91% and a return on equity of 9.53%. The firm earned $1.05 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same period in the prior year, the company posted $0.22 earnings per share. The company’s revenue for the quarter was up 3.2% compared to the same quarter last year. On average, equities analysts predict that Select Medical Holdings Corp. will post $0.68 earnings per share for the current fiscal year.

A number of research firms have recently commented on SEM. Zacks Investment Research lowered shares of Select Medical Holdings Corp. from a hold rating to a sell rating in a research note on Thursday, October 6th. JMP Securities lowered shares of Select Medical Holdings Corp. from a market perform rating to an underperform rating and set a $10.00 price objective on the stock. in a research note on Wednesday, September 28th.

In related news, insider David S. Chernow sold 90,164 shares of the stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $12.11, for a total transaction of $1,091,886.04. Following the transaction, the insider now directly owns 1,010,453 shares of the company’s stock, valued at $12,236,585.83. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider David S. Chernow sold 50,000 shares of the stock in a transaction on Friday, September 30th. The stock was sold at an average price of $13.51, for a total transaction of $675,500.00. Following the transaction, the insider now directly owns 799,075 shares in the company, valued at $10,795,503.25. The disclosure for this sale can be found here. Corporate insiders own 19.63% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This news story was published by Financial Market News and is the sole property of of Financial Market News. If you are accessing this news story on another domain, it was illegally copied and reposted in violation of international copyright laws. The legal version of this news story can be read at http://www.financial-market-news.com/select-medical-holdings-corp-sem-issues-fy16-earnings-guidance/1208317/.

A number of hedge funds and other institutional investors have recently modified their holdings of SEM. Price T Rowe Associates Inc. MD raised its position in shares of Select Medical Holdings Corp. by 14.8% in the third quarter. Price T Rowe Associates Inc. MD now owns 17,769,860 shares of the company’s stock valued at $239,893,000 after buying an additional 2,285,267 shares in the last quarter. BlackRock Fund Advisors increased its position in Select Medical Holdings Corp. by 2.9% in the second quarter. BlackRock Fund Advisors now owns 7,394,101 shares of the company’s stock valued at $80,374,000 after buying an additional 211,316 shares during the last quarter. BlackRock Institutional Trust Company N.A. increased its position in Select Medical Holdings Corp. by 2.8% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 2,618,002 shares of the company’s stock valued at $28,458,000 after buying an additional 70,222 shares during the last quarter. Northern Trust Corp increased its position in Select Medical Holdings Corp. by 3.7% in the third quarter. Northern Trust Corp now owns 1,914,591 shares of the company’s stock valued at $25,848,000 after buying an additional 67,473 shares during the last quarter. Finally, Marshall Wace LLP increased its position in Select Medical Holdings Corp. by 14.8% in the second quarter. Marshall Wace LLP now owns 1,087,452 shares of the company’s stock valued at $11,821,000 after buying an additional 140,084 shares during the last quarter. 82.45% of the stock is currently owned by institutional investors and hedge funds.

About Select Medical Holdings Corp.

Select Medical Holdings Corporation is an operator of specialty hospitals and outpatient rehabilitation clinics. The Company, through its contract therapy business, provides medical rehabilitation services on a contracted basis to nursing homes, hospitals, assisted living and senior care centers, schools and work sites.

5 Day Chart for NYSE:SEM

Receive News & Ratings for Select Medical Holdings Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical Holdings Corp. and related companies with MarketBeat.com's FREE daily email newsletter.